buflomedil has been researched along with Diseases, Peripheral Vascular in 5 studies
buflomedil: RN given refers to parent cpd; synonym LL 1656 refers to HCl; structure
| Excerpt | Relevance | Reference |
|---|---|---|
| " We performed an international, multicenter, randomized, double-blind, placebo-controlled trial to investigate whether long-term administration of oral buflomedil could reduce the rate of cardiovascular events in patients with intermittent claudication." | 5.13 | Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study. ( Becker, F; Leizorovicz, A, 2008) |
| "Patients with type 2 diabetes mellitus have an increased vascular risk and a series of modifiable risk factors play a crucial role in the atherosclerotic process." | 2.45 | Buflomedil: potential new indications for an old agent. ( Hatzitolios, AI; Papadimitriou, DK; Tsantilas, D; Tziomalos, K, 2009) |
| "Food and Drug Administration for the treatment of intermittent claudication, several supplements and investigational agents have been evaluated." | 2.45 | Pharmacologic therapy for intermittent claudication. ( Dobesh, PP; Persson, EL; Stacy, ZA, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Backer, TL | 1 |
| Vander Stichele, RH | 1 |
| Van Bortel, LM | 1 |
| Tsantilas, D | 1 |
| Hatzitolios, AI | 1 |
| Tziomalos, K | 1 |
| Papadimitriou, DK | 1 |
| Dobesh, PP | 1 |
| Stacy, ZA | 1 |
| Persson, EL | 1 |
| Leizorovicz, A | 1 |
| Becker, F | 1 |
| Conte, MS | 1 |
2 reviews available for buflomedil and Diseases, Peripheral Vascular
| Article | Year |
|---|---|
Buflomedil: potential new indications for an old agent.
Topics: Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Peripheral Vascular Diseases; Pyrrolidines | 2009 |
Pharmacologic therapy for intermittent claudication.
Topics: Cilostazol; Clinical Trials as Topic; Dietary Supplements; Drugs, Investigational; Exercise Therapy; | 2009 |
2 trials available for buflomedil and Diseases, Peripheral Vascular
| Article | Year |
|---|---|
Letter by De Backer et al regarding article, "Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study".
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Disease Progr | 2008 |
Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Disease Progr | 2008 |
1 other study available for buflomedil and Diseases, Peripheral Vascular
| Article | Year |
|---|---|
Buflomedil in peripheral arterial disease: trials and tribulations.
Topics: Adrenergic alpha-Antagonists; Cardiovascular Diseases; Disease Progression; Humans; Intermittent Cla | 2008 |